
Glimip MP 2mg/500mg/15mg Tablet
Marketer
Roussel Laboratories Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimip MP 2mg/500mg/15mg Tablet
Metformin/Glimepiride/Pioglitazone 2mg/500mg/15mg tablets offer a triple-action approach to managing blood glucose. This combined medication, used alongside a healthy diet and regular exercise, assists adults with type 2 diabetes in achieving better glycemic control. It enhances insulin effectiveness, contributing to reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Taking this medication with food minimizes gastrointestinal discomfort. Should you miss a dose, take it immediately; however, if your next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals raises the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or nursing individuals should seek medical counsel before use. Kidney function tests will be performed before treatment begins. Limit alcohol consumption as it can heighten the risk of adverse reactions.
Primary Ingredients of Glimip MP 2mg/500mg/15mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Glimip MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimip MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimip MP 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Glimip MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimip MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Glimip MP 2mg/500mg/15mg Tablet should be administered with a meal.
How Glimip MP 2mg/500mg/15mg Tablet works:
Glimip MP 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimip MP 2mg/500mg/15mg Tablet with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glimip MP 2mg/500mg/15mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimip MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimip MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated for those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimip MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimip MP 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimip MP 2mg/500mg/15mg Tablet :
Should you forget a Glimip MP 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Glimip MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
